Bevacizumab,Durvalumab,Olaparib,Carboplatin,Paclitaxel
AstraZeneca,roche,Merck
['durva', 'gyn', 'ovarian', 'olaparib']
addition of olaparib and durvalumab to standard of care may prolong progression-free survival in patients with advanced ovarian cancer #gyncsm #ovariancancer #asco23 #oncology
News and views from the world of clinical oncology and hematology